Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Delamanid is approved by the EMA for multidrug‑resistant pulmonary Tuberculosis (TB), but it does not have a standard marketing approval by the U.S. FDA and has only been accessible there under investigational or emergency use pathways.
The medicine is only on the complementary list. For these items specialized diagnostic or monitoring or specialist training are needed. An item may also be listed as complementary on the basis of higher costs or a less attractive cost-benefit ratio.
…